Rubella control in Papua New Guinea: Age-specific immunity informs strategies for introduction of rubella vaccine
Michaela Riddell, Nicolas Senn, C John Clements, Linda Hobday, Benjamin Cowie, Jonah Kurubi, Ali Kevin, Peter Siba, John C Reeder, Chris Morgan
Vaccine | ELSEVIER SCI LTD | Published : 2012
The authors thank Matthew Omena, Sauli Bebes and Doris Manong and staff at the PNG Institute for Medical Research in Goroka and Yagaum as well as staff at the Central Public Health Laboratory, Port Moresby for assistance in specimen collection and testing. We appreciate staff at the World Health Organization, Port Moresby for their assistance in country and with specimen transport. We thank all participants who agreed to provide specimens for this study. The catalytic modelling techniques used in this study were based on those used in the infectious disease modelling course developed by Emilia Vynnycky, Richard White and Azra Ghani of the London School of Hygiene and Tropical Medicine, London, United Kingdom. No specific funding was obtained to support this study. However the authors acknowledge funding for the individual studies which enabled this work. Burnet authors acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program. The EPO study was supported by UNICEF. The Well Baby Study was supported by the RE Ross Trust, Victoria through the PNG Child Health Research Fellowship. The Madang Fever Aetiology study was funded by the PNG Institute for Medical Research and The Australian National Health and Medical Research Council.